Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil for permanent post-stroke non-fluent aphasia: randomized Phase 3 study
TCTR20251117014Phase 3Recruiting
- Sponsor
- Ratchadaphiseksomphot Endowment Fund
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of donepezil in aphasia, sponsored by Ratchadaphiseksomphot Endowment Fund. Started Feb 2026; status: recruiting.
02
Drugs
donepezil
03
Conditions
aphasia
Beyond the preview
Go deeper on TCTR20251117014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20251117014.